References
- Mosqueda-Garcia R., Eskay R., Zamir N., Palkovits M., Kunos G. Opioid-mediated cardiovascular effects of clonidine in spontaneously hypertensive rats: elimination by neonatal treatment with monosodium glutamate. Endocrinology 1986; 118: 1814–1822
- Kunos G., Mosqueda-Garcia R., Mastrianni J. A. Endorphinergic mechanism in the central cardiovascular and analgesic effects of clonidine. Canad. J. Physiol. Pharmacol. 1987; 65: 1624–1632
- Mosqueda-Garcia R., Kunos G. Opiate receptors and the endorphin mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced μ-subtype to δ-subtype changes. Proc. Natl. Acad. Sci. USA 1987; 84: 8637–8641
- Mastrianni J. A., Ingenito A. J. On the relationship between clonidine hypotension and brain β-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers. J. Pharmacol. Exp. Ther. 1987; 242: 378–387
- van Giersbergen P. L.M., De Jong W. Antagonism of the hypotension and bradycardia induced by α-methyldopa in conscious normotensive rats. J. Pharmacol. Exp. Ther. 1988; 244: 341–347
- Onesti G., Schwartz A. B., Kim K. E., Swartz C., Brest A. N. Pharmacodynamic effects of a new antihypertensive drug. Catapres (ST-155). Circulation 1969; 39: 219–226
- De Jonge A., Timmermans P. B.M.W.M., van Zwieten P. A. Participation of cardiac presynaptic α2-adrenoceptors in the bradicardiac effects of clonidine and analogues. Naunyn Schmiedebergs Arch. Pharmacol. 1981; 317: 8–12
- Mosqueda-Garcia R., Kunos G. Peripheral opiate receptors are not involved in the naloxone-sensitive cardiovascular effects of clonidine in rats. Brain Research 1988; 442: 119–123